resTORbio, Inc. (TORC) financial statements (2021 and earlier)

Company profile

Business Address 500 BOYLSTON STREET
BOSTON, MA 02116
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:927
Cash and cash equivalents347
Other undisclosed cash, cash equivalents, and short-term investments58 
Prepaid expense21
Other current assets00
Other undisclosed current assets(0)101
Total current assets:93110
Noncurrent Assets
Property, plant and equipment00
Restricted cash and investments00
Total noncurrent assets:10
TOTAL ASSETS:94110
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities126
Accounts payable73
Accrued liabilities53
Total current liabilities:126
Noncurrent Liabilities
Liabilities, other than long-term debt00
Other liabilities00
Total noncurrent liabilities:00
Total liabilities:126
Stockholders' equity
Stockholders' equity attributable to parent82104
Common stock00
Additional paid in capital236176
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(154)(71)
Total stockholders' equity:82104
TOTAL LIABILITIES AND EQUITY:94110

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(85)(40)
Operating loss:(85)(40)
Nonoperating income32
Investment income, nonoperating3 
Other nonoperating income (expense)(0)2
Loss from continuing operations before income taxes:(83)(38)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(83)(38)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(83)(38)
Comprehensive loss:(83)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(83)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: